Role of inhaled nitric oxide as a selective pulmonary vasodilator in pediatric cardiac surgical practice

Indian Journal of Pediatrics

Volumn 66, Issue 3, 1999, Pages 357-361

  Murthy, K S ^a   Rao, Suresh G ^a   Prakash, K Shiva ^a   Robert, C ^a   Dhinakar, S ^a   Cherian, K M ^a  

^a INSTITUTE OF CARDIOVASCULAR DISEASES   (India)

Author keywords

Congenital heart defects; Inhaled nitric oxide; Paediatric cardiac surgery; Pulmonary hypertensive crisis; Selective pulmonary vasodilator

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; DRUG EFFECT; FEMALE; HEART SURGERY; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; LUNG BLOOD VESSEL; LUNG PRESSURE; MALE; MEAN ARTERIAL PRESSURE; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; VASODILATATION;

EID: 0033037678     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02845523     Document Type: Article

References (13)

1. Furchgott RF, Lawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288 : 373-376.
2. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biologic activity of endothelium-derived relaxation factor. Nature 1987; 373 : 524-526.
3. Ignarro L, Buga G, Woods K, Byrns R, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci 1987; 84 : 9265-9269.
4. Ignarro L. Biological actions and properties of endothelial derived nitric oxide formed and released from artery and vein. Cir Res 1989; 65 : 1-21.
5. Gruetter C, Gruetter G, Lyon J, Ignarro L. Relationship between cyclic guanosine 3, 5-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide. J Pharmacol Exp Ther 1981; 219 : 181-6.
6. Journois D, Ponard P, Mauriat P, Malahere T, Vouhe P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardio Vasc Surg 1994; 107; 1129-1135.
7. Curran RD, Mavroudis C, Becker CL, Sautel M, Lales VR, Wessel DL. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Ann Thorac Surg 1995; 60 : 1765-71.
8. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardio-pulmonary bypass. Circulation 1993; 88 : 2128-38.
9. Murthy KS, Suresh Rao, Shivaprakash K et al. Inhaled nitric oxide as therapy for pulmonary hypertension in postoperative cases of congenital heart defects. Indian Heart Journal. 1996; 48 : 695-698.
10. Miller OI, Cehrmajer DS, Dreanfield JE, Macral DJ. Very low dose inhaled nitric oxide as a selective pulmonary vasodilator after operations for congenital heart disease. Thorac Cardio Vasc Surg 1994; 108 : 487-94.
11. Roberts JD, Polaner DM, Lang P, Zapal WM. Inhaled nitric oxide in persistant pulmonary hypertension of the new-born. Lancet 1992; 340 : 818-9.
12. Shah N, Jacob T, Exler R, Morrow S, Ford H, Albanese C et al. Inhaled nitric oxide in congenital diaphragmatic hernia. J Pediatr Surg 1994; 29 : 1010-1005.
13. Rossaint R, Halke KJ, Lopez F, Llama K, Pison U, Zapor WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Eng J Med 1993; 328 : 399-405.